BeStock  
Stocks › Biotechnology › SVRA

Savara SVRA

US equityMarket cap rank #3240Biotechnology
$4.88 +$0.23 (+4.95%)
Pre-market · Oct 8, 8:20 am ET · After hours $4.98 +1.95%
Open$4.74
Prev close$4.65
Day range$4.69 – $5.05
Volume2.42M
Market cap$1.00B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-8.4x
CheapRich

Around its usual level · 51st percentile, 5-year average -8.5x

Price / book7.0x
CheapRich

Near the top of its 5-year range · 88th percentile, 5-year average 4.2x

#4627 of 5317 stocks by PB (1 = cheapest)

P/E over five years

-18x-12x-6x-1xOct '21Apr '24Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$5.00
Price vs. fair value-2.4%Close to the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 6.98 – 4.16 88% (pricier than usual) #4627 of 5317 (1 = cheapest)
PE -8.41 -7.62 -8.54 51% (pricier than usual) –
PS – 44.81 16,172.25 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$5.00
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on SVRA.

Leave a comment

Scroll to Top